- Report
- December 2023
- 326 Pages
Global
From €4058EUR$4,197USD£3,462GBP
- Report
- March 2024
- 193 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- April 2024
- 184 Pages
Global
From €5270EUR$5,450USD£4,496GBP
- Report
- April 2024
- 135 Pages
Global
From €3770EUR$3,899USD£3,217GBP
- Report
- October 2023
- 190 Pages
Global
From €4738EUR$4,900USD£4,042GBP
- Report
- February 2024
- 110 Pages
Global
From €4593EUR$4,750USD£3,919GBP
- Report
- January 2024
- 200 Pages
Global
From €4013EUR$4,150USD£3,424GBP
- Report
- October 2023
- 145 Pages
Global
From €3046EUR$3,150USD£2,599GBP
- Report
- March 2020
- 293 Pages
Global
From €4737EUR$4,899USD£4,042GBP
- Book
- January 2018
- 272 Pages
- Book
- February 2016
- 1416 Pages
- Book
- February 2016
- 384 Pages
- Book
- April 2014
- 552 Pages
- Book
- September 2010
- 418 Pages
- Book
- November 2008
- 288 Pages
The Stem Cell Biology market is a rapidly growing field of research and development that focuses on the use of stem cells for medical treatments. Stem cells are undifferentiated cells that can be used to create specialized cells and tissues, and are capable of self-renewal. This makes them a valuable resource for regenerative medicine, drug discovery, and tissue engineering. Stem cell biology is a multidisciplinary field that involves the study of stem cell biology, stem cell engineering, and stem cell therapy.
The Stem Cell Biology market is driven by the increasing demand for stem cell-based treatments and therapies. This demand is driven by the potential of stem cells to treat a variety of diseases and conditions, including cancer, diabetes, and neurological disorders. Additionally, the development of new technologies and techniques for stem cell research and development is driving the growth of the market.
Companies in the Stem Cell Biology market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Stemcell Technologies, and Cellular Dynamics International. Show Less Read more
